Jounce Therapeutics Inc (JNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JNCE | ZTS | TAK | UTHR | NBIX |
| Company | Jounce Therapeutics Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.9200 | 180.80 | 13.40 | 330.37 | 146.23 |
| High | 1.9300 | 182.17 | 13.56 | 333.32 | 148.88 |
| Low | 1.8800 | 178.78 | 13.40 | 325.54 | 144.71 |
| Last | 1.8800 | 180.76 | 13.51 | 332.63 | 145.28 |
| Change | -0.0500 | +2.18 | +0.15 | +3.47 | -0.41 |
| % Change | -2.59% | +1.22% | +1.12% | +1.05% | -0.28% |
| Volume | 11,600,600 | 1,532,900 | 2,261,400 | 327,200 | 554,600 |
| 20-Day Average Volume | 1,541,820 | 2,149,655 | 1,809,295 | 499,780 | 706,705 |
| Previous Close | 1.9300 | 178.58 | 13.36 | 329.16 | 145.69 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.9078 | 176.00 | 13.21 | 322.27 | 141.63 |
| 20-Day Raw Stochastic | 16.67% | 77.81% | 75.38% | 77.55% | 71.24% |
| 20-Day Relative Strength | 62.73% | 58.40% | 55.77% | 72.02% | 58.07% |
| Weighted Alpha | -65.90 | -1.90 | -10.65 | +51.80 | +38.40 |
| Today's Opinion | 24% Buy | 40% Buy | 40% Sell | 100% Buy | 100% Buy |
| Previous Opinion | 40% Buy | 40% Buy | 56% Sell | 100% Buy | 100% Buy |
| Last Month's Opinion | 24% Buy | 64% Sell | 100% Sell | 100% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.59% since 04/26/23 | +1.56% since 07/15/24 | +0.90% since 07/15/24 | +1.64% since 07/15/24 | -1.48% since 07/15/24 |
| Low | 1.8800 on 05/03/23 | 176.17 on 07/19/24 | 13.24 on 07/19/24 | 325.54 on 07/22/24 | 143.09 on 07/19/24 |
| High | 1.9500 on 04/28/23 | 184.84 on 07/17/24 | 13.75 on 07/17/24 | 339.56 on 07/17/24 | 150.39 on 07/16/24 |
| 1-Month | |||||
| %Chg | +1.62% since 04/03/23 | +5.65% since 06/21/24 | +7.22% since 06/21/24 | +5.25% since 06/21/24 | +7.96% since 06/21/24 |
| Low | 1.8400 on 04/04/23 | 166.45 on 06/26/24 | 12.77 on 06/24/24 | 308.68 on 06/24/24 | 132.62 on 06/26/24 |
| High | 1.9800 on 04/17/23 | 184.84 on 07/17/24 | 13.75 on 07/17/24 | 339.56 on 07/17/24 | 150.39 on 07/16/24 |
| 3-Month | |||||
| %Chg | +55.37% since 02/03/23 | +24.20% since 04/22/24 | +1.12% since 04/22/24 | +42.11% since 04/22/24 | +8.69% since 04/22/24 |
| Low | 0.8957 on 03/10/23 | 145.18 on 04/23/24 | 12.57 on 06/20/24 | 233.27 on 04/24/24 | 129.33 on 06/20/24 |
| High | 1.9800 on 04/17/23 | 184.84 on 07/17/24 | 13.75 on 07/17/24 | 339.56 on 07/17/24 | 150.39 on 07/16/24 |
| 6-Month | |||||
| %Chg | -10.48% since 11/03/22 | -5.46% since 01/22/24 | -8.65% since 01/22/24 | +53.82% since 01/22/24 | +3.92% since 01/22/24 |
| Low | 0.5773 on 12/13/22 | 144.80 on 04/22/24 | 12.57 on 06/20/24 | 208.62 on 02/08/24 | 128.00 on 02/07/24 |
| High | 2.1180 on 11/09/22 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 339.56 on 07/17/24 | 150.39 on 07/16/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 98,954 | 81,485,168 | 42,282,220 | 14,600,219 | 14,661,805 |
| Shares Outstanding, K | 52,635 | 456,295 | 3,164,837 | 44,356 | 100,637 |
| Annual Sales | 82,000,000 | 8,544,000,000 | 29,419,960,000 | 2,327,500,000 | 1,887,100,000 |
| Annual Net Income | -50,920,000 | 2,344,000,000 | 994,060,000 | 984,800,000 | 249,700,000 |
| Last Quarter Sales | 82,000,000 | 2,190,000,000 | 6,938,670,000 | 677,700,000 | 515,300,000 |
| Last Quarter Net Income | 50,960,000 | 599,000,000 | -46,010,000 | 306,600,000 | 43,400,000 |
| 60-Month Beta | 0.75 | 0.86 | 0.54 | 0.55 | 0.37 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.60 on 11/10/22 | 1.38 on 05/02/24 | 0.00 on 05/09/24 | 6.17 on 05/01/24 | 0.42 on 05/01/24 |
| Latest Earnings Date | 05/04/23 | 08/06/24 | 07/31/24 | 08/07/24 | 08/01/24 |
| Most Recent Dividend | N/A | 0.432 on 07/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 07/18/24 | 03/27/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 33.25 | 8.65 | 15.54 | 39.71 |